NCT05347849View on ClinicalTrials.gov

Single Ascending Dose Study With BPL-003 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

February 14, 2022

Primary Completion Date

January 19, 2024

Study Completion Date

January 19, 2024

Conditions
Pharmacokinetics in Healthy Adults
Interventions
DRUG

BPL-003

A single dose of BPL-003 will be administered intranasally

OTHER

Placebo

A single dose of placebo will be administered intranasally

Trial Locations (1)

Unknown

Hammersmith Medicines Research, London

Sponsors
All Listed Sponsors
lead

Beckley Psytech Limited

INDUSTRY

NCT05347849 - Single Ascending Dose Study With BPL-003 in Healthy Subjects | Biotech Hunter | Biotech Hunter